Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease -: Results from the Lung Health Study

被引:400
作者
Kanner, RE
Anthonisen, NR
Connett, JE
机构
[1] LHS Coordinating Ctr, Minneapolis, MN 55414 USA
[2] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA
关键词
smoking; chronic obstructive pulmonary disease; lower respiratory infections; chronic bronchitis;
D O I
10.1164/ajrccm.164.3.2010017
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
We analyzed Lung Health Study (LHS) data to assess the effect of self-reported lower respiratory illnesses resulting in physician visits (LRI) on lung function. Participants were 5,887 smokers aged 35-60 yr, FEV1/FVC < 0.70 and FEV1 of 55-90% predicted. Two-thirds were randomized into an intensive smoking cessation program (SI); one-third were advised only to stop smoking (UC). For 5 yr participants had annual spirometry and questioning regarding LRI. SI had greater rates of smoking cessation than usual care (UC) with fewer LRI (p = 0.0008). Sustained quitters had fewer LRI than continuing smokers (p = 0.0003). In the year LRI occurred, FEV1 did not change in sustained quitters, but decreased significantly in smokers (p = 0.0001) with some recovery the following year if no LRI occurred. Over 5 yr, LRI had a significant effect on rate of decline of FEV1 only in smokers. In smokers averaging one LRI/yr over 5 yr there were additional declines in FEV1 of 7 ml/yr (p = 0.001). Smokers with more than one LRI/yr had greater declines. Chronic bronchitis was associated with increased frequencies of LRI, but did not affect their influence on lung function. Smoking and LRI had an interactive effect on FEV1, in people with mild COPD, and in smokers frequent LRI may influence the longterm course of the disease.
引用
收藏
页码:358 / 364
页数:7
相关论文
共 35 条
[1]
Proportion of community-acquired pneumonia cases attributable to tobacco smoking [J].
Almirall, J ;
González, CA ;
Balanzó, X ;
Bolíbar, I .
CHEST, 1999, 116 (02) :375-379
[2]
ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[3]
EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[4]
BATES DV, 1973, AM REV RESPIR DIS, V108, P1043
[5]
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[6]
CYTO-TOXIC T-CELLS CLEAR VIRUS BUT AUGMENT LUNG PATHOLOGY IN MICE INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS [J].
CANNON, MJ ;
OPENSHAW, PJM ;
ASKONAS, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :1163-1168
[7]
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease [J].
Collet, JP ;
Shapiro, S ;
Ernst, P ;
Renzi, P ;
Ducruet, T ;
Robinson, A ;
Gauthier, G ;
Beaupre, A ;
Gregoire, P ;
Jacquemin, P ;
Plante, F ;
Lachance, Y ;
Provost, G ;
Hernandez, P ;
JeanFrancois, R ;
Charbonneau ;
Inhaber, N ;
Braidy, J ;
Jeanneret, A ;
Bolduc, P ;
Leblanc, PP ;
Olivenstein, R ;
Mannix, S ;
Chrysler, B ;
Wolkove, N ;
Kreisman, H ;
Frank ;
Fox, J ;
Colman, N ;
Gruber, J ;
Zidulka ;
Gursahaney, A ;
Matouk ;
Eidelman, D ;
Julien, M ;
Malo, J ;
Dandurand, R ;
Skamene, E ;
Suissa, S ;
Choi, S ;
Martin, J ;
Dankoff, G ;
Enjalbert, M ;
Lauener, PA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1719-1724
[8]
CONNETT JE, 1993, CONTROLLED CLIN TRIA, V14, P3
[9]
COSTABEL U, 1992, RESPIRATION, V59, P17
[10]
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659